News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Gentiae Clinical Research Awarded Thorough QT Study By Biotech Industry Leader
August 9, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Gentiae Clinical Research, Inc., the leader in comprehensive cardiac assessment services, announced today the commencement of a major $1.1M thorough QT study (TQT) on behalf of a Top 10 Biotech company.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
China
AstraZeneca Finds Another Jewel in China With up to $2B For KRAS Inhibitor
December 22, 2025
·
1 min read
·
Annalee Armstrong
Business
BioSpace
Editors’ Top 5 Biggest News Stories of the Year
December 22, 2025
·
10 min read
·
Annalee Armstrong
Layoff Tracker
Voyager Loses 30 Employees After Novartis Prunes Deal
December 19, 2025
·
98 min read
·
BioSpace Editorial Staff
Rare diseases
Kyowa Kirin Could Get Windfall From Updated Newborn Screening Recommendations
December 19, 2025
·
2 min read
·
Dan Samorodnitsky
